Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

237 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Pretransplant desensitization of donor-specific anti-HLA antibodies with plasmapheresis and immunoglobulin produces equivalent outcomes to patients with no donor specific antibodies in haploidentical hematopoietic cell transplant.
Cochran HC, Slade MJ, Liu C, Gao F, Godbole S, Pruitt A, De Togni E, Grossman B, Abboud R. Cochran HC, et al. Among authors: abboud r. Leuk Lymphoma. 2024 Dec;65(12):1811-1819. doi: 10.1080/10428194.2024.2376172. Epub 2024 Jul 11. Leuk Lymphoma. 2024. PMID: 38990135
Severe Cytokine-Release Syndrome after T Cell-Replete Peripheral Blood Haploidentical Donor Transplantation Is Associated with Poor Survival and Anti-IL-6 Therapy Is Safe and Well Tolerated.
Abboud R, Keller J, Slade M, DiPersio JF, Westervelt P, Rettig MP, Meier S, Fehniger TA, Abboud CN, Uy GL, Vij R, Trinkaus KM, Schroeder MA, Romee R. Abboud R, et al. Among authors: abboud cn. Biol Blood Marrow Transplant. 2016 Oct;22(10):1851-1860. doi: 10.1016/j.bbmt.2016.06.010. Epub 2016 Jun 16. Biol Blood Marrow Transplant. 2016. PMID: 27318038 Free PMC article.
The effect of donor type on outcomes in adults with acute myeloid leukemia after reduced-intensity hematopoietic peripheral blood cell transplant - a retrospective study.
Rashid N, Slade M, Abboud R, Gao F, DiPersio JF, Westervelt P, Uy G, Stockerl-Goldstein K, Romee R, Schroeder MA. Rashid N, et al. Among authors: abboud r. Transpl Int. 2020 Sep;33(9):1089-1098. doi: 10.1111/tri.13659. Epub 2020 Jun 19. Transpl Int. 2020. PMID: 32468720 Free PMC article.
Increased early mortality after fludarabine and melphalan conditioning with peripheral blood grafts in haploidentical hematopoietic cell transplantation with post-transplant cyclophosphamide.
Eastburg L, Russler-Germain DA, DiPersio JF, Fountaine T, Andolina JR, Abboud R, Huselton E. Eastburg L, et al. Among authors: abboud r. Leuk Lymphoma. 2022 Jan;63(1):222-226. doi: 10.1080/10428194.2021.1978087. Epub 2021 Nov 18. Leuk Lymphoma. 2022. PMID: 34794373 Free article.
Letermovir Discontinuation at Day 100 After Allogeneic Stem Cell Transplant Is Associated With Increased CMV-Related Mortality.
Liu LW, Yn A, Gao F, Olson M, Crain M, Abboud R, Westervelt P, Abboud C, Vij R, Stockerl-Goldstein K, Pusic I, Cashen AF, Schroeder MA. Liu LW, et al. Among authors: abboud c, abboud r. Transplant Cell Ther. 2022 Aug;28(8):510.e1-510.e9. doi: 10.1016/j.jtct.2022.05.020. Epub 2022 May 20. Transplant Cell Ther. 2022. PMID: 35598841 Free article.
Pretransplant Desensitization of Donor-Specific Anti-HLA Antibodies with Plasmapheresis and Immunoglobulin Produces Equivalent Outcomes to Patients with No Donor Specific Antibodies in Haploidentical Hematopoietic Cell Transplant.
Cochran H, Slade M, Gao F, Godbole S, Pruitt A, De Togni E, Liu C, Grossman B, Abboud R. Cochran H, et al. Among authors: abboud r. Res Sq [Preprint]. 2024 Jan 8:rs.3.rs-3832106. doi: 10.21203/rs.3.rs-3832106/v1. Res Sq. 2024. Update in: Leuk Lymphoma. 2024 Dec;65(12):1811-1819. doi: 10.1080/10428194.2024.2376172 PMID: 38260672 Free PMC article. Updated. Preprint.
237 results